BioMerieux Net Current Debt 2017-2024 | BMXMF

BioMerieux annual/quarterly net current debt history and growth rate from 2017 to 2024. Net current debt can be defined as the net amount of debt repaid and issued with short-term maturities.
  • BioMerieux net current debt for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • BioMerieux net current debt for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • BioMerieux annual net current debt for 2024 was $0B, a 0% decline from 2023.
  • BioMerieux annual net current debt for 2023 was $0B, a 0% decline from 2022.
  • BioMerieux annual net current debt for 2022 was $0B, a 0% decline from 2021.
BioMerieux Annual Net Current Debt
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
2017 $N/A
2016 $N/A
2015 $N/A
Sector Industry Market Cap Revenue
Medical Medical Services $16.861B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.275B 26.68
CVS Health (CVS) United States $86.641B 10.77
Elevance Health (ELV) United States $86.192B 11.12
Cencora (COR) United States $58.035B 20.19
DiDi Global (DIDIY) China $23.015B 24.45
Natera (NTRA) United States $22.934B 0.00
Labcorp Holdings (LH) United States $21.811B 17.69
EUROFINS SCIENT (ERFSF) Luxembourg $13.798B 0.00
Solventum (SOLV) United States $13.056B 13.82
CochLear (CHEOY) Australia $12.649B 0.00
ICON (ICLR) Ireland $11.674B 10.85
Revvity (RVTY) United States $11.530B 19.84
Viatris (VTRS) United States $10.575B 3.63
Avantor (AVTR) United States $9.220B 13.40
HealthEquity (HQY) United States $9.070B 39.73
Medpace Holdings (MEDP) United States $8.930B 23.72
Sonic Healthcare (SKHHY) Australia $8.455B 0.00
Charles River Laboratories (CRL) United States $7.368B 14.44
Caris Life Sciences,�Inc (CAI) $6.821B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.386B 25.83
BrightSpring Health Services (BTSG) United States $4.138B 37.97
Sotera Health (SHC) United States $3.213B 18.26
Surgery Partners (SGRY) United States $2.813B 36.58
Alignment Healthcare (ALHC) United States $2.740B 0.00
Concentras Parent (CON) United States $2.711B 15.67
GeneDx Holdings (WGS) United States $2.599B 100.11
Organon (OGN) United States $2.563B 2.72
PACS (PACS) United States $1.980B 0.00
Ardent Health (ARDT) United States $1.957B 8.34
Progyny (PGNY) United States $1.878B 41.34
Premier (PINC) United States $1.779B 13.51
GoodRx Holdings (GDRX) United States $1.750B 35.00
Teladoc Health (TDOC) United States $1.475B 0.00
Pediatrix Medical (MD) United States $1.205B 9.17
Establishment Labs Holdings (ESTA) $1.184B 0.00
CareDx (CDNA) United States $1.071B 16.72
Agilon Health (AGL) United States $0.956B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.799B 7.48
Nutex Health (NUTX) United States $0.683B 10.34
LifeMD (LFMD) United States $0.625B 0.00
Embecta (EMBC) United States $0.563B 3.80
InnovAge Holding (INNV) United States $0.529B 0.00
Enhabit (EHAB) United States $0.484B 39.83
SBC Medicals (SBC) United States $0.481B 0.00
Sonida Senior Living (SNDA) United States $0.475B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.57
Omada Health (OMDA) $0.453B 0.00
Performant Healthcare (PHLT) United States $0.313B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.259B 0.00
Beauty Health (SKIN) United States $0.246B 0.00
So-Young (SY) China $0.240B 0.00
Oncology Institute (TOI) United States $0.195B 0.00
DocGo (DCGO) United States $0.163B 26.67
Sera Prognostics (SERA) United States $0.154B 0.00
Pheton Holdings (PTHL) China $0.120B 0.00
KindlyMD (NAKA) United States $0.086B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
ModivCare (MODV) United States $0.049B 0.00
Biodesix (BDSX) United States $0.037B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.034B 0.00
Basel Medical Group (BMGL) Singapore $0.032B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00